UniSuper Management Pty Ltd Buys 4,793 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

UniSuper Management Pty Ltd raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 59,354 shares of the medical equipment provider’s stock after purchasing an additional 4,793 shares during the period. UniSuper Management Pty Ltd’s holdings in Intuitive Surgical were worth $30,980,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. Atala Financial Inc bought a new stake in Intuitive Surgical in the 4th quarter valued at about $25,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC bought a new position in shares of Intuitive Surgical in the 4th quarter worth $31,000. Finally, Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at $36,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 492 shares of Intuitive Surgical stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $282,299.76. Following the completion of the transaction, the senior vice president now owns 4,056 shares of the company’s stock, valued at $2,327,251.68. The trade was a 10.82 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Fredrik Widman sold 810 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now directly owns 473 shares in the company, valued at approximately $271,397.94. The trade was a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,754 shares of company stock worth $17,691,621. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 2.1 %

ISRG opened at $509.03 on Thursday. The company has a market capitalization of $181.31 billion, a price-to-earnings ratio of 79.41, a PEG ratio of 5.85 and a beta of 1.43. The firm has a 50-day moving average price of $559.82 and a 200-day moving average price of $532.42. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of recent research reports. Truist Financial dropped their price objective on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research note on Monday, March 17th. Stifel Nicolaus lifted their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Evercore ISI increased their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Robert W. Baird cut their target price on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 18th. Finally, Barclays increased their price target on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.